New European Health Claim for Solactis

19 Sep 2016 --- Solactis Group, specialist of bioscience based ingredients designed for human nutrition and animal feed companies, has welcomed a new approval from the European authorities, stating, “Consumption of foods/drinks containing Galactofructose instead of sugars induces a lower blood glucose rise after their consumption compared to sugar-containing foods/drinks.”

The approval confirms the strategic orientations on the new health benefits of Non Digestible Carbohydrates (NDC).

As Solactis Galactofructose is neither digested, nor absorbed in the small intestine. It does not participate in the glycaemic response and does not provide 4 kcal/g. Like fibers, it passes intact in the colon where it is fermented by the colonic microbiota. Consequently, it meets the EFSA description of NDC.

Behind the simple action of replacing digestible carbohydrates by NDC, Solactis Galactofructose also sparks the interest of food product developers.

“Behind the simple action of replacing digestible carbohydrates by NDC, Solactis Galactofructose sparks the interest of food product developers. Indeed, it potentially offers new innovative mechanisms compared to ‘standard’ fiber or other NDC’s, especially through a promising role of the gut microbiota, and could trigger a modulation of glucose absorption,” said Ms Marion Lenoir (PhD), Groupe SOLACTIS R&D Manager.

The blood glucose response regulation is involved into two main benefits for end users. Firstly, slow release energy management can be achieved by replacing sugars with NDC, especially GalactoFructose, as it modulates the blood glucose peak supporting a smooth sugar release and avoiding the critical lack of energy. Secondly, it claims to promote fat storage for better weight control by managing blood glucose response after food intake.

“Combining its good technical behavior and these new features of Solactis Galactofructose is increasing the interest of food products manufacturers with a hot positioning offering solutions for the over-weight, and also on energy management markets. Approaching the consumers with the willingness to keep their blood sugar under control is very attractive and proposes possibilities for differentiation.” declares Moez Kmicha, Groupe SOLACTIS Business Development Manager. 

“As an outperforming NDC, Solactis Galactofructose proposes a new health claim that will perfectly fit with applications such as high proteins yogurts, cereals bars, healthy snacking, functional & energy waters.”